Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
OPCH

Option Care Health Inc

OPCH

29.90USD+0.23 (+0.78%)Market Closed
Watchlist

Market Summary

USD29.90+0.23
Market Closed
0.78%

OPCH Alerts

  • 1 major insider buys recently.
  • Big jump in Earnings (Y/Y)

OPCH Stock Price

View Fullscreen

OPCH RSI Chart

OPCH Valuation

Market Cap

5.3B

Price/Earnings (Trailing)

20.57

Price/Sales (Trailing)

1.26

EV/EBITDA

10.74

Price/Free Cashflow

16.37

OPCH Price/Sales (Trailing)

OPCH Profitability

EBT Margin

8.19%

Return on Equity

17.88%

Return on Assets

7.94%

Free Cashflow Yield

6.11%

OPCH Fundamentals

OPCH Revenue

Revenue (TTM)

4.2B

Revenue Y/Y

7.06%

Revenue Q/Q

2.24%

OPCH Earnings

Earnings (TTM)

257.4M

Earnings Y/Y

45.02%

Earnings Q/Q

-50.79%

Price Action

Last 7 days

-1.2%

Last 30 days

5.1%

Last 90 days

-12.9%

Trailing 12 Months

-0.4%

How does OPCH drawdown profile look like?

OPCH Financial Health

Current Ratio

1.79

OPCH Investor Care

Buy Backs (1Y)

2.61%

Diluted EPS (TTM)

1.41

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20234.0B4.1B4.2B0
20223.6B3.7B3.8B3.9B
20213.1B3.2B3.3B3.4B
20202.5B2.8B2.9B3.0B
20192.0B2.0B2.1B2.3B
20181.1B1.3B1.6B1.9B
2017914.9M900.6M874.7M817.2M
2016976.3M961.9M939.2M935.6M
2015945.7M962.5M978.2M982.2M
2014809.8M867.6M908.4M922.7M
2013688.0M704.4M724.7M769.5M
2012579.3M603.6M640.2M662.6M
2011461.7M492.6M523.6M554.5M
20101.3B1.4B1.5B430.7M
20091.4B1.4B1.4B1.3B
20081.2B1.3B1.4B1.4B
20070000
20060000
20050000
20040000
20030000
20020000
20010000
20000000
19990000
19980000
19970000

Latest Insider Trading transactions for OPCH

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Oct 30, 2023
bierbower elizabeth d
bought
79,110
26.37
3,000
-
Aug 17, 2023
pate r carter
bought
50,278
34.32
1,465
-
Aug 14, 2023
smyser collin
bought
86,725
34.69
2,500
gc & corporate secretary
Aug 11, 2023
kraemer harry m jansen jr
bought
1,904,520
34.6276
55,000
-
May 19, 2023
smyser collin
sold (taxes)
-6,804
28.59
-238
gc & corporate secretary
May 19, 2023
smyser collin
acquired
-
-
812
gc & corporate secretary
May 17, 2023
betten elizabeth quadros
acquired
-
-
7,185
-
May 17, 2023
pate r carter
acquired
-
-
9,117
-
May 17, 2023
sahney nitin
acquired
-
-
8,817
-
May 17, 2023
deckmann natasha
acquired
-
-
5,322
-

1–10 of 50

Which funds bought or sold OPCH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 06, 2023
Raleigh Capital Management Inc.
new
-
6,826
6,826
-%
Dec 06, 2023
CITIGROUP INC
added
6.66
633,500
10,853,300
0.01%
Nov 30, 2023
Neo Ivy Capital Management
new
-
621,000
621,000
0.27%
Nov 24, 2023
DEUTSCHE BANK AG\
reduced
-34.73
-9,162,720
17,009,900
0.01%
Nov 22, 2023
Graham Capital Management, L.P.
new
-
2,816,420
2,816,420
0.07%
Nov 21, 2023
Walleye Capital LLC
new
-
625,326
625,326
-%
Nov 21, 2023
COMERICA BANK
added
3,212
15,398,000
15,404,000
0.08%
Nov 16, 2023
Creative Planning
added
20.67
55,115
328,579
-%
Nov 16, 2023
Financial Gravity Asset Management, Inc.
reduced
-96.88
-799
35.00
-%
Nov 15, 2023
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
added
3.49
1,000
34,000
-%

1–10 of 44

Latest Funds Activity

Are funds buying OPCH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own OPCH
No. of Funds

Schedule 13G FIlings of Option Care Health Inc

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Sep 11, 2023
vanguard group inc
10.09%
18,142,964
SC 13G/A
Jun 12, 2023
fmr llc
-
0
SC 13G/A
Jun 12, 2023
walgreens boots alliance, inc.
0.0%
0
SC 13D/A
Mar 03, 2023
walgreens boots alliance, inc.
6.0%
10,771,926
SC 13D/A
Feb 14, 2023
price t rowe associates inc /md/
1.4%
2,469,612
SC 13G/A
Feb 09, 2023
vanguard group inc
8.53%
15,524,268
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Jan 23, 2023
blackrock inc.
10.9%
19,772,386
SC 13G/A
Sep 08, 2022
blackrock inc.
10.1%
18,297,262
SC 13G
Aug 18, 2022
walgreens boots alliance, inc.
14.4%
26,247,092
SC 13D/A

Recent SEC filings of Option Care Health Inc

View All Filings
Date Filed Form Type Document
Nov 01, 2023
4
Insider Trading
Oct 25, 2023
8-K
Current Report
Oct 25, 2023
10-Q
Quarterly Report
Sep 11, 2023
SC 13G/A
Major Ownership Report

Peers (Alternatives to Option Care Health Inc)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
508.7B
360.0B
2.46% 0.72%
23.46
1.41
14.24% 11.62%
96.7B
347.8B
9.25% -26.74%
11.1
0.28
10.34% 159.11%
91.1B
189.9B
-12.37% -22.06%
13.64
1.92
5.24% 22.27%
69.2B
63.2B
11.16% 6.57%
12.11
1.1
5.62% 6.32%
39.4B
150.1B
4.91% -14.72%
16.13
0.26
6.04% 21.35%
MID-CAP
9.8B
11.9B
26.82% 43.59%
16.13
0.82
2.36% -10.41%
9.6B
14.0B
6.07% 6.08%
14.25
0.69
6.03% -8.61%
8.6B
2.2B
-1.60% 9.83%
35.34
3.88
4.50% -6.69%
6.7B
2.9B
-0.53% -12.01%
-365.93
2.34
13.16% -106.47%
2.6B
4.1B
13.56% -40.93%
9.25
0.63
-25.26% -41.25%
SMALL-CAP
1.6B
1.3B
4.12% 12.39%
34.86
1.17
27.06% -27.04%
1.5B
1.0B
10.48% -13.37%
25.78
1.44
10.84% 30.19%
1.0B
3.0B
22.30% 77.33%
-8.11
0.34
6.98% 58.07%
35.8M
-
8.80% -76.75%
-2.47
-
- -27.68%
15.8M
20.7M
12.00% -11.27%
54.39
0.76
6.53% -78.75%

Option Care Health Inc News

Latest updates
MarketBeat09 Dec 202306:27 pm9 hours ago
Yahoo Finance07 Dec 202305:48 pm2 days ago
Yahoo Finance06 Dec 202309:11 pm3 days ago
Nasdaq05 Dec 202311:22 am4 days ago
Simply Wall St22 Nov 202308:00 am17 days ago
GuruFocus.com15 Nov 202306:08 am24 days ago
Yahoo Finance13 Nov 202308:00 am26 days ago
Seeking Alpha07 Nov 202308:00 am32 days ago
Seeking Alpha07 Nov 202308:00 am32 days ago
Seeking Alpha03 Nov 202307:00 am36 days ago
Nasdaq03 Nov 202307:00 am36 days ago
Yahoo Finance30 Oct 202307:00 am40 days ago
Yahoo Finance24 Oct 202307:00 am46 days ago
The Acquirer's Multiple09 Oct 202307:00 am2 months ago

Financials for Option Care Health Inc

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue2.2%1,0931,0691,0161,0271,021981916927892860759805782741705721616497476506494
Cost Of Revenue------------------127121121115
Gross Profit1.4%25425122923121821720121220319916518417416615817613810198.00111108
Operating Expenses2.8%17316816216315715814915115015113613914014314916214910993.0013595.00
  S&GA Expenses3.0%15815414814814214213413713513412012312312512914413399.0083.0016386.00
EBITDA Margin1.7%0.11*0.11*0.08*0.08*0.08*0.08*0.08*0.07*0.07*0.06*0.05*0.06*0.07*0.04*0.03*------
Interest Expenses-10.7%12.0013.0014.0015.0014.0013.0012.0014.0016.0017.0019.0024.0025.0031.0028.0030.0022.0012.0011.0036.00-14.97
Income Taxes-66.4%14.0041.0015.0017.0013.0014.0011.00-28.483.001.001.001.001.001.001.001.004.00-5.42-1.40-2.050.00
Earnings Before Taxes-54.9%70.0015654.0065.0052.0048.0041.0047.0039.0033.00-1.5818.002.00-----14.01-10.27-15.00-8.00
EBT Margin3.7%0.08*0.08*0.05*0.05*0.05*0.05*0.04*0.03*0.03*0.02*0.00*0.00*0.00*-0.03*-0.03*------
Net Income-50.8%56.0011439.0048.0039.0034.0030.0075.0035.0032.00-2.8618.002.00-7.67-19.91-15.81-42.79-13.60-3.713.002.00
Net Income Margin5.4%0.06*0.06*0.04*0.04*0.05*0.05*0.05*0.04*0.02*0.02*0.00*0.00*-0.01*-0.03*-0.04*------
Free Cashflow-67.5%53.0016284.0025.0080.0010027.0051.0046.0070.0015.0012.0045.0031.0013.00------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets-2.3%3,2443,3213,1303,1133,0732,9862,8782,7912,7862,7192,6402,6472,6682,6262,6132,5902,5826015971,428579
  Current Assets-6.8%1,1161,1981,030994952877806710811736665657676638601559545178171467172
    Cash Equivalents-12.4%38644129829425520414611920115810999.0014011877.0067.0053.0047.0038.0036.0032.00
  Inventory-4.4%25126325022423623221718319017417415915514913911610928.0027.0083.0023.00
  Net PPE1.1%10810710610896.0010510911210711111612111311812613313227.0028.0093.0025.00
  Goodwill0.0%1,5401,5411,5341,5331,5331,5121,4791,47833.001,4291,4291,4291,4291,4291,4281,4261,419632632632-
Liabilities-2.3%1,8041,8461,7801,7271,7361,7011,6571,6151,6891,6621,6221,6321,6751,7581,7421,6831,660676657825616
  Current Liabilities-6.6%62466861956558755550846048646042043443339537933032011611624096.00
  Long Term Debt--------1,066---1,1241,1721,2851,2861,2861,266519507539497
    LT Debt, Current0%6.006.006.006.006.006.006.006.0012.0012.0012.009.009.009.009.009.007.00--4.00-
    LT Debt, Non Current0.0%1,0571,0571,0581,0581,0591,0591,0591,0601,1181,1191,1211,1151,1631,2751,2761,2771,259--535-
Shareholder's Equity-2.4%1,4401,4751,3501,3861,3371,2851,2221,1761,0971,0571,0181,016993868870907922584597603600
  Retained Earnings16.4%40034423019014310470.0040.00-35.60-71.08-102-100-117-119-111-91.95-76.14-787-771-16.03-745
  Additional Paid-In Capital0.8%1,1981,1881,1811,1771,1721,1681,1431,1391,1351,1331,1301,1291,1291,0091,0091,0081,008614616620620
Accumulated Depreciation------------------76.0010410198.00
Shares Outstanding-1.5%177180180182182181180180180180180180184177177177163143143143143
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations-64.0%61,038,000169,536,00089,752,00043,455,00087,138,000104,273,00032,681,00065,310,00051,225,00073,654,00018,380,00025,664,00048,338,00034,987,00018,403,00022,897,000-5,836,00013,326,0009,080,00012,230,00032,525,000
  Share Based Compensation20.2%9,235,0007,685,0005,988,0004,202,0004,005,0004,398,0004,178,0003,329,0002,516,0002,525,0001,205,000332,0001,170,000661,000757,000272,0002,745,000569,000584,000468,000-138,000
Cashflow From Investing30.7%-14,316,000-20,649,000-5,760,000-3,626,000-34,474,000-64,593,000-5,359,000-80,945,000-4,936,000-22,537,000-3,123,000-14,004,000-3,602,000-3,375,000-5,353,000-15,142,000-704,818,000-3,135,000-4,731,000-6,370,000-23,687,000
Cashflow From Financing-1744.6%-101,399,000-5,497,000-80,402,000-1,111,000-1,242,00018,766,000-1,145,000-65,798,000-2,959,000-2,953,000-5,160,000-52,442,000-22,788,0009,243,000-2,862,0006,512,000716,588,000-1,038,000-3,038,000-1,038,000-11,748,000
  Buy Backs13720.1%100,108,000-735,00075,735,000------------------

OPCH Income Statement

2023-09-30
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
NET REVENUE$ 1,093,014$ 1,020,918$ 3,177,934$ 2,917,522
COST OF REVENUE838,748802,9172,443,8342,281,685
GROSS PROFIT254,266218,001734,100635,837
OPERATING COSTS AND EXPENSES:    
Selling, general and administrative expenses158,214142,015459,644417,771
Depreciation and amortization expense15,00515,26844,41746,027
Total operating expenses173,219157,283504,061463,798
OPERATING INCOME81,04760,718230,039172,039
OTHER INCOME (EXPENSE):    
Interest expense, net(11,786)(13,997)(38,816)(39,008)
Equity in earnings of joint ventures1,2731,4724,1074,065
Other, net(449)3,88884,4873,891
Total other (expense) income(10,962)(8,637)49,778(31,052)
INCOME BEFORE INCOME TAXES70,08552,081279,817140,987
INCOME TAX EXPENSE13,78313,25869,90437,960
NET INCOME56,30238,823209,913103,027
OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX:    
Change in unrealized gain (loss) on cash flow hedges, net of income tax benefit (expense) of $8, $(1,398), $57 and $(5,917), respectively539,255(99)24,962
OTHER COMPREHENSIVE INCOME (LOSS)539,255(99)24,962
NET COMPREHENSIVE INCOME$ 56,355$ 48,078$ 209,814$ 127,989
EARNINGS PER COMMON SHARE:    
Earnings per share, basic (in dollars per share)$ 0.31$ 0.21$ 1.17$ 0.57
Earnings per share, diluted (in dollars per share)$ 0.31$ 0.21$ 1.16$ 0.57
Weighted average common shares outstanding, basic (in shares)178,826181,884179,956180,829
Weighted average common shares outstanding, diluted (in shares)180,528183,022181,286181,760

OPCH Balance Sheet

2023-09-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
CURRENT ASSETS:  
Cash and cash equivalents$ 386,489$ 294,186
Accounts receivable, net382,957377,542
Inventories251,366224,281
Prepaid expenses and other current assets95,47398,330
Total current assets1,116,285994,339
NONCURRENT ASSETS:  
Property and equipment, net107,960108,321
Operating lease right-of-use asset83,73272,424
Intangible assets, net20,86822,371
Referral sources, net323,126341,744
Goodwill1,540,2461,533,424
Other noncurrent assets51,39940,313
Total noncurrent assets2,127,3312,118,597
TOTAL ASSETS3,243,6163,112,936
CURRENT LIABILITIES:  
Accounts payable429,536378,763
Accrued compensation and employee benefits81,15976,906
Accrued expenses and other current liabilities88,92184,302
Current portion of operating lease liability18,46819,380
Current portion of long-term debt6,0006,000
Total current liabilities624,084565,351
NONCURRENT LIABILITIES:  
Long-term debt, net of discount, deferred financing costs and current portion1,057,0161,058,204
Operating lease liability, net of current portion85,42371,441
Deferred income taxes33,92122,154
Other noncurrent liabilities3,0899,683
Total noncurrent liabilities1,179,4491,161,482
Total liabilities1,803,5331,726,833
STOCKHOLDERS’ EQUITY:  
Preferred stock; $0.0001 par value; 12,500,000 shares authorized, no shares outstanding as of September 30, 2023 and December 31, 202200
Common stock; $0.0001 par value: 250,000,000 shares authorized, 182,901,785 shares issued and 177,129,378 shares outstanding as of September 30, 2023; 182,341,420 shares issued and 181,957,698 shares outstanding as of December 31, 20221818
Treasury stock; 5,772,407 and 383,722 shares outstanding, at cost, as of September 30, 2023 and December 31, 2022, respectively(179,205)(2,403)
Paid-in capital1,197,8741,176,906
Retained earnings400,336190,423
Accumulated other comprehensive income21,06021,159
Total stockholders’ equity1,440,0831,386,103
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$ 3,243,616$ 3,112,936
OPCH
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
 CEO
 WEBSITEwww.optioncarehealth.com
 EMPLOYEES5597

Option Care Health Inc Frequently Asked Questions


What is the ticker symbol for Option Care Health Inc? What does OPCH stand for in stocks?

OPCH is the stock ticker symbol of Option Care Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Option Care Health Inc (OPCH)?

As of Fri Dec 08 2023, market cap of Option Care Health Inc is 5.3 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of OPCH stock?

You can check OPCH's fair value in chart. The fair value of Option Care Health Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Option Care Health Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for OPCH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Option Care Health Inc a good stock to buy?

The fair value guage provides a quick view whether OPCH is over valued or under valued. Whether Option Care Health Inc is cheap or expensive depends on the assumptions which impact Option Care Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for OPCH.

What is Option Care Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 08 2023, OPCH's PE ratio (Price to Earnings) is 20.57 and Price to Sales (PS) ratio is 1.26. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OPCH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Option Care Health Inc's stock?

In the past 10 years, Option Care Health Inc has provided 0.015 (multiply by 100 for percentage) rate of return.